Laboratory News and Research

RSS

METTLER TOLEDO’s First-Defect-Stop Guide shows how lean management concepts can be applied to the lab

Lean Management techniques applied to the laboratory have been shown to improve quality and efficiency.

From Mettler-Toledo International Inc. 28 Sep 2017

Surgical screws being developed from donated human bone material

Biomechanics from TU Graz, are developing surgical screws from donated human bone material for foot and jaw surgery together with surgebright, a start-up from Linz, Austria.

28 Sep 2017

Research findings can lead to new treatment for patients with fatal glandular cancer

A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon.

28 Sep 2017

Researchers test way to stop or slow cardiac fibrosis after heart injury

Early research results suggest scientists might be on to a way to preserve heart function after heart attacks or for people with inherited heart defects called congenital cardiomyopathies.

28 Sep 2017

BD launches first automated phenotypic test for CPO detection

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of the first automated phenotypic test to detect and classify carbapenemase-producing organisms (CPO).

From BD (Becton, Dickinson and Company) 28 Sep 2017

Participants show great interest in WHINN - Week of Health and Innovation 2017

Health innovation. Things are looking good in terms of the number of participants at the 2017 WHINN - Week and Health and Innovation knowledge festival.

28 Sep 2017

Northumbria researcher develops new, faster and safer way to diagnose Ebola virus

A new, faster and safer way of diagnosing the Ebola virus has been developed by an academic from Northumbria University, Newcastle.

28 Sep 2017

Gene editing technique helps uncover potential new drug targets for KRAS-driven cancers

Cancers driven by mutations in the KRAS gene are among the most deadly. For decades, researchers have tried unsuccessfully to directly target mutant KRAS proteins as a means to treat tumors.

28 Sep 2017

FDA approves FreeStyle Libre Flash Glucose Monitoring System for adult patients with diabetes

The U.S. Food and Drug Administration today approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip.

27 Sep 2017

Scientists map brain circuitry underlying the drive to consume salt

While the average American's high-salt diet has been linked to high blood pressure and cardiovascular disease, the truth is we couldn't live without this once scarce mineral.

27 Sep 2017

Study identifies potential biomarker for onset, progression of MS

An article published in Experimental Biology and Medicine identifies Opioid Growth Factor (OGF) as a novel biomarker for the onset and progression of multiple sclerosis (MS).

27 Sep 2017

Columbia University receives $9.6 million NIH grant for ME/CFS research center

The National Institutes of Health has awarded a five-year $9.6 million grant to the Center for Infection and Immunity at Columbia University's Mailman School of Public Health to create the Center for Solutions for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (CfS for ME/CFS), an inter-disciplinary, inter-institutional research group dedicated to understanding the biology of the disease in order to develop effective means to diagnose, treat and prevent it.

27 Sep 2017

Researchers explore potential of traditional Chinese ink for cancer treatment

For hundreds of years, Chinese calligraphers have used a plant-based ink to create beautiful messages and art. Now, one group reports in ACS Omega that this ink could noninvasively and effectively treat cancer cells that spread, or metastasize, to lymph nodes.

27 Sep 2017

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.

27 Sep 2017

Cellular messaging mechanism could lead to new way of treating disease

A newly discovered cellular messaging mechanism could lead to a new way to deliver therapeutics to tissues affected by disease, according to a new study from Harvard T.H. Chan School of Public Health.

27 Sep 2017

Neuroscientist awarded $2.64 million NIH grant to explore benefits of napping for preschoolers

Neuroscientist Rebecca Spencer at the University of Massachusetts Amherst recently received a five-year, $2.64 million grant from the National Institutes of Health to explore, in a series of laboratory and preschool-based studies, whether mid-day napping benefits learning in young children and helps them cope with emotions.

27 Sep 2017

Research shows insulin as key determinant of embryonic stem cell potency

New research conducted at the stem cell centre, DanStem, at the University of Copenhagen shows that insulin is a key determinant of embryonic stem cell potency in mammals.

26 Sep 2017

Cyclists perform better in open-ended laboratory tests, study finds

Scientists at the University of Kent's School of Sport and Exercise Sciences have discovered that cyclists can perform better when they do not have to pace their efforts.

26 Sep 2017

MIPT scientist proposes unique model to predict cancer development

A scientist from the Moscow Institute of Physics and Technology has proposed a model that can predict the number of key carcinogenic events for each cancer type based on the relationship between morbidity and age.

26 Sep 2017

SBP researcher awarded $10.8 million grant to pursue development of new drug for substance abuse

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce the National Institute on Drug Abuse at the National Institutes of Health has awarded Nicholas Cosford, Ph.D., a three-year, $10.8 million grant to pursue the preclinical development of a new class of medicine to treat substance use disorders.

26 Sep 2017